Table 2. Association of L-FABP protein expression with clinical pathologic characteristics in patients with HCC.
| Characteristics | Low (1) | Intermediate (2) | High (3) | P value |
|---|---|---|---|---|
| Age (years) Mean ±SD | 53.2 ± 8.5 | 52.4 ± 10.6 | 59.3 ± 8.2 | 0.089 a |
| Age >= 53.5 | 9 (47.4) | 30 (51.7) | 8 (66.7) | 0.555 b |
| Sex | ||||
| Female | 4 (21.1) | 7 (11.9) | 1 (8.3) | 0.509 b |
| Male | 15 (78.9) | 52 (88.1) | 11 (91.7) | |
| Grade | 0.484 b | |||
| G1 | 2 (10.5) | 3 (5.1) | 1 (8.3) | |
| G2 | 15 (78.5) | 46 (78.0) | 7 (58.3) | |
| G3 | 2 (10.5) | 10 (16.9) | 4 (33.3) | |
| pT (invasion depth) | 0.169 b | |||
| T1 | 2 (10.5) | 8 (14.3) | 2 (16.7) | |
| T2 | 9 (47.4) | 20 (35.7) | 2 (16.7) | |
| T3 | 6 (31.6) | 28 (50.0) | 7 (58.3) | |
| T4 | 2 (10.5) | 0 (0.0) | 1 (8.3) | |
| pN (lymph node metastasis) | 0.759 b | |||
| N0 | 19 (100.0) | 54 (98.2) | 11 (100.0) | |
| N1 | 0 (0.0) | 1 (1.8) | 0 (0.0) | |
| pM (distant metastasis) | 0.578 b | |||
| M0 | 19 (100.0) | 54 (96.4) | 11 (100.0) | |
| M1 | 0 (0.0) | 2 (3.6) | 0 (0.0) | |
| TNM stage | 0.546 b | |||
| I | 2 (10.5) | 8 (14.3) | 2 (16.7) | |
| II | 9 (47.4) | 20 (35.7) | 2 (16.7) | |
| III | 8 (42.1) | 25 (44.6) | 8 (66.7) | |
| IV | 0 (0.0) | 3 (5.4) | 0 (0.0) |
Abbreviations: HCC, hepatocellular carcinoma; N, number.
a
ANOVA test.
b
Chi-square test.